Radiopharm Theranostics Limited (RDPTF) Gross margin 2023–2025
Radiopharm Theranostics Limited (RDPTF) gross margin by fiscal year — reported gross profit divided by reported revenue.
1.1%FY2025 · since FY2023: 100.0% → 1.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 1.1% | -98.9 pp |
| FY2024 | 100.0% | +0.0 pp |
| FY2023 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RDPTF financial trends
RDPTF RevenueRDPTF Net incomeRDPTF Net marginRDPTF Gross profitRDPTF Operating incomeRDPTF Operating marginRDPTF Operating cash flowRDPTF Free cash flowRDPTF Capital expendituresRDPTF Return on equityRDPTF Stock buybacksRDPTF Dividends paidRDPTF Total assetsRDPTF Total liabilitiesRDPTF Shareholders’ equityRDPTF overview →